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Abstract 
Background 
For a comprehensive health sector response to intimate partner violence (IPV), interventions 
should target individual and health facility levels, along with the broader health systems level 
which includes issues of governance, financing, planning, service delivery, monitoring and 
evaluation, and demand generation. This study aims to map and explore the integration of 
IPV response in the Spanish national health system. 
Methods 
Information was collected on five key areas based on WHO recommendations: policy 
environment, protocols, training, monitoring and prevention. A systematic review of public 
documents was conducted to assess 39 indicators in each of Spain’s 17 regional health 
systems. In addition, we performed qualitative content analysis of 26 individual interviews 
with key informants responsible for coordinating the health sector response to IPV in Spain. 
Results 
In 88% of the 17 autonomous regions, the laws concerning IPV included the health sector 
response, but the integration of IPV in regional health plans was just 41%. Despite the 
existence of a supportive national structure, responding to IPV still relies strongly on the will 
of health professionals. All seventeen regions had published comprehensive protocols to 
guide the health sector response to IPV, but participants recognized that responding to IPV 
was more complex than merely following the steps of a protocol. Published training plans 
existed in 43% of the regional health systems, but none had institutionalized IPV training in 
medical and nursing schools. Only 12% of regional health systems collected information on 
the quality of the IPV response, and there are many limitations to collecting information on 
IPV within health services, for example underreporting, fears about confidentiality, and 
underuse of data for monitoring purposes. Finally, preventive activities that were considered 
essential were not institutionalized anywhere. 
Conclusions 
Within the Spanish health system, differences exist in terms of achievements both between 
regions and between the areas assessed. Progress towards integration of IPV has been notable 
at the level of policy, less outstanding regarding health service delivery, and very limited in 
terms of preventive actions. 
Keywords 
Health system, Health policy, Intimate partner violence, Spain, Mixed methods, Content 
analysis 
Background 
Men’s intimate partner violence (IPV) against women, defined as “any behaviour within an 
intimate relationship that causes physical, sexual or psychological harm, including acts of 
physical aggression, sexual coercion, psychological abuse and controlling behaviours”, is 
widespread [1,2]. The most recent global estimates of violence against women show that 35% 
of women worldwide have experienced physical and/or sexual intimate partner violence or 
non-partner sexual violence [3]. Within the EU-27, between 20% and 25% of all women have 
experienced IPV at least once in their lifetime [4]. 
IPV has devastating effects on the health and wellbeing of women and children [1,3,5,6]. 
Health services can play a key role in the prevention and management of IPV because of the 
many harmful effects on health they must attend to, and also due to the fact that women may 
access health services more often than other public services. Health care, and especially 
primary health care, can be an IPV survivor’s first and only point of contact with public 
service professionals [7,8]. Moreover, this contact can open doors for improved health and 
wellbeing; research shows that trained health providers improve IPV detection and referral to 
specialist violence agencies [9] - where intensive advocacy interventions can be provided 
[10]. A recent randomised controlled trial conducted in Australia showed that screening and 
brief counselling in primary care settings improved doctors’ follow up inquiry about 
women’s and children’s safety at 12 months, but did not improve other outcomes, such as 
quality of life, safety behaviour or anxiety [11]. 
There is general consensus that the health sector should carry out the following actions 
[1,6,8,12,13]: ask all women about violence, stay alert to possible signs and symptoms, 
provide health care assistance and register all cases, provide information on available 
resources, coordinate with other professionals and institutions, and provide evidence of the 
magnitude and seriousness of IPV. All these actions should be carried out while ensuring 
privacy and confidentiality, in a supportive environment where women’s experiences are 
validated and their decisions are respected [1]. However, integration of these actions varies 
significantly between countries, regions, and even between health care facilities [12,14]. 
There have been several studies that assess how health providers and/or health facilities 
respond to IPV, in terms of exploring knowledge, opinions and practices; measuring possible 
changes in connection with interventions; and focusing specifically on adopting IPV 
screening [9,15-23]. However, there is less research that explores the response at the health 
system level [8,13]. It is important to fill this gap, since successful and sustained policy 
integration in the health sector cannot be achieved through isolated strategies directed 
towards individuals and/or health facilities alone, rather they should target larger health 
system functions, including: i) governance, ii) financing, iii) planning, iv) service delivery, 
and v) monitoring and evaluation [24,25]. Research shows that in order to sustain long-term 
improvements in the health sector response to IPV, changes should be made not only at the 
individual provider/facility level through training, but should also involve changes in health 
policies, protocols, managerial structures and practices [13,26,27]. 
This study aims to map and explore the integration of the IPV response in the Spanish 
national health system. In Spain the “Gender Based Violence Law”, enacted in 2004, has 
been recognized as one of the most progressive and comprehensive pieces of legislation on 
gender-based violence worldwide. The law specifically addresses the responsibilities of the 
health sector [28-31]. The Law establishes an array of measures, including judicial system 
reforms, and the implementation of a comprehensive network of social services aimed at 
protecting the rights and security of women exposed to IPV. The Law also establishes the 
need to implement preventive measures to challenge gender inequality at the broader social 
level. Regarding the role of the health sector, the Law states that health services should be 
aware of possible cases of violence, manage them, and engage in a multidisciplinary response 
in coordination with other institutions and sectors. In order to monitor these actions, the 
‘National Commission against Gender Based Violence’ (NCAGBV) was created within the 
Inter-territorial Council of the National Health System, which is the highest level of decision-
making within the Spanish health system [32]. The NCAGBV is comprised of delegates from 
each autonomous region and national representatives of the Ministry of Health. 
By describing the situation in Spain and highlighting its strengths and challenges, we aim to 
provide information useful not only for this country, but for informing health systems in 
general in their efforts towards achieving IPV integration. 
Methods 
The setting: IPV and the Spanish health system 
Though Spanish legislation refers to gender-based violence, the concept used in this study is 
IPV. During data collection it became clear that the health sector response has focused 
specifically on IPV, and less so on other forms of gender based violence–i.e. sexual assault 
by non-partners, trafficking, female genital mutilation-that have just recently begun to be 
addressed. According to a survey conducted with 11,000 women using primary health care 
facilities in Spain, the reported lifetime prevalence of IPV in 2007 was 32% [33]. 
The Spanish health system is highly decentralized. The 17 autonomous regions–each with its 
own parliament and government-and 2 autonomous cities located in the North of Morocco 
are in charge of health planning, public health, and management of health services. Health 
services are offered through a network of primary health care centres, which is made up of a 
multidisciplinary team of family doctors, nurses, social workers, midwives and 
paediatricians, and hospitals. In some regional health systems there are also other specialized 
services offered at the community level, which coordinate closely with primary health care 
facilities but are not part of them. These include mental health, reproductive health, and 
addictive behaviour units. 
At the level of regional health systems (RHSs), coordination for IPV is the responsibility of 
regional delegates to the NCAGBV and civil servants. These civil servants, together with 
representatives from academic institutions and other government agencies with expertise or 
responsibilities related to IPV, participate in 5 working groups that have been created by the 
NCAGBV to coordinate actions related to: 1) training, 2) evaluation, 3) protocols, 4) 
information systems and indicators, and 5) ethical issues. The Observatory of Women’s 
Health, a technical body created within the Spanish Ministry of Health, acts as secretariat of 
the NCAGBV and gives support to the working groups [32,34-38]. See Figure 1 for a 
summary of the different bodies created in the Spanish health system to promote and monitor 
the response to IPV (Figure 1). In Spain, the integration of IPV response has focused on first-
line health services, i.e. primary health care centres. Progressively, other specialized services 
-such as mental health clinics, hospital emergency departments and other specialized 
departments-are beginning to be incorporated. 
Figure 1 Bodies created within the Spanish national health system to coordinate and 
monitor IPV response, grounded on the 2004 GBV Law. 
In Spain the primary responsibility for health system implementation lies at the regional 
level, therefore, in this study we explored the 17 regional health systems of the autonomous 
regions; the autonomous cities of Ceuta and Melilla, located in the North of Morocco were 
excluded since their health systems depend on a different structure (INGESA). 
Research methodology 
This study aims to map and explore the integration of IPV response in the Spanish national 
health system. We conducted a systematic review of public documents regarding the health 
system’s response to IPV in Spain as well as qualitative interviews with key informants 
within the Spanish health system. Based on the WHO recommendations for the health sector 
response to violence against women [1,6], five key areas of assessment were identified: 1) 
policy environment and networks, 2) protocols and guidelines to direct the healthcare 
response, 3) training of health professionals, 4) accountability and monitoring mechanisms, 
and 5) prevention and promotion. For each of these areas, quantitative and qualitative 
information was collected. Information collected through the documentary review was used 
to map the integration of IPV within Spain’s decentralized health systems, while qualitative 
information from the interviews permitted a deeper exploration of the process. For a 
summary of the methodological steps, see Figure 2. A more detailed description of the 
methodology can be found elsewhere [39]. 
Figure 2 Methods for data collection and analysis. 
Mapping: systematic review of public documents 
Content analysis was conducted as described by Ortiz-Barreda and Vives Cases [28-30]. 
Existing documents were systematically analyzed to assess 39 indicators-from the five areas 
described above-in each of the 17 RHSs. These indicators were selected based on WHO and 
national guidelines. However, during data collection some indicators that were considered 
important were not available, i.e. even if indicators related to funding for IPV programmes 
would have been important to collect, they were unavailable. Regional documents reviewed 
included laws, health plans and protocols concerning the issue of IPV within the autonomous 
health systems. National documents reviewed included reports of IPV for the years 2005-
2011 (see Additional file 1 for a summary of the main documents reviewed). For each RHS, 
indicators were assessed as present or absent. 
Exploring: qualitative interviews with key informants 
Individual interviews were conducted from July 2012 to March 2013, with a theoretical 
sample of 23 key informants from the autonomous regions and three informants at the 
national level. Informants in the autonomous regions were civil servants of the RHSs in 
charge of coordinating the health-sector response to IPV. Their backgrounds varied; the 
majority were medical doctors (14), although there were also nurses (3), psychologists (2), 
one anthropologist, one midwife, one social worker, and one sociologist. They were all 
participating–or had participated-in the working groups and some of them had also 
participated in the NCAGBV. One informant per RHS was contacted first. In some RHSs 
another informant was included due to his/her experience in certain areas of interest to the 
study. Informants at the national level were representatives of the Observatory of Women’s 
Health and academic institutions–one had a pharmaceutical degree and was in charge of the 
Observatory of Women’s Health, another was a nurse working at the Observatory, and the 
third was a midwife working in an academic institution who also held an advisory role for the 
Women’s Health Observatory. We selected civil servants at the managerial level, and not 
politicians, because they remain in their positions for a longer time and play a more direct 
and active role in implementing the health system’s response to IPV in their regions. They 
were chosen based on their status as privileged informants-able to contribute significantly to 
our research-through theoretical sampling. All of the prospective informants who were 
chosen agreed to participate. Fifteen of the interviews were conducted face to face, 11 were 
phone interviews, and the average duration was one hour. All but two of the participants were 
women. First contacts were facilitated through the National Observatory of Women’s Health 
and subsequent contacts came from interviewees themselves, through snowball sampling. 
The average duration of the interviews was one hour; 16 interviews were conducted face to 
face, while 10 were phone interviews. The interviews started with an open question 
encouraging participants to describe how the process of integrating IPV has occurred in their 
region–or nationally in the case of national level informants. Afterwards, questions were 
asked in order to explore the five areas of interest. 
All the interviews were held in Spanish, recorded and transcribed verbatim. Transcripts were 
imported into the software Atlas.ti-5 to manage the analytical process. We used qualitative 
content analysis as described by Graneheim and Lundman [40], focusing on the manifest 
content of the text. First, we identified the meaning units that referred to the five major 
content areas previously described. Within each of the major content areas, identified 
meaning units were condensed and later coded. Afterwards, codes were grouped together to 
build categories. The coding and analysis was done using the original Spanish. 
Data collected through the individual interviews served to triangulate and to complement the 
information previously gathered through the documentary review, while information from the 
documentary review served to further explore regional particularities during the qualitative 
interviews. Preliminary results were sent to the participants for member checking: nine of 
them responded with comments that were incorporated into the final versions of the tables. 
Additional file 2 summarizes the application of the RATS guidelines for qualitative research, 
to assess this manuscript. 
The study was approved by the Ethical Committee of the University of Alicante. Each 
participant in the study was asked to provide written informed consent prior to conducting the 
interviews. Information that could identify the respondents was eliminated. 
Results 
Results are presented for each of the five areas assessed; the results from the documentary 
review are presented in a table, which is followed by the findings from the analysis of the 
qualitative interviews. Figure 3 presents the summary of the five major content areas, and the 
categories emerging from the qualitative content analysis of the interviews. 
Figure 3 Summary of major content areas explored and emerging categories. 
Policy environment and networks 
Fifteen out of 17 of the Regional Health Systems had passed Autonomic Laws against IPV 
that explicitly mention the health sector’s responsibilities. However, the inclusion of IPV 
within regional health plans occurred in only 7 out of 17 RHSs, and the integration of IPV 
indicators within “program contracts”-agreements between the managerial and the 
operational levels of the health system that prioritize certain health indicators to be achieved-
occurred only in 7 out of 17 RHSs. In 13 RHSs there were informal teams in charge of 
coordinating IPV actions, but only 6 RHSs had a person or team officially designated. 
Thirteen out of 17 autonomous regions had intersectorial committees, and 15 had developed 
protocols for an intersectorial response to IPV that included the health sector. See Table 1. 
Table 1 Indicators related to Policy environment and networks (Published documents and committees as per December 2012) 
 TOTAL 
n (%)5 
Andalucía Aragon Asturias Baleares Canarias Cantabria C-La 
Mancha 
C-Leon Cataluña C 
Valenciana 
Extremadura Galicia La Rioja Madrid Murcia Navarra País 
Vasco 
Criteria Indicator 
Policies and 
procedures in place 
in health system 
Autonomic Law against IPV 
mentions explicitly health 
sector response 
15 (88) + + + + + + - + + - + + + + + + + 
Latest autonomic health 
policy/plan includes IPV as 
health problem 
7 (41) + - + + - + - + - - - - + + - - - 
IPV management included in 
primary health care portfolio 
12 (71) + + + - + + - + + + + + + + - - - 
IPV indicators included in 
primary health care program 
contracts1 
7 (44) + - + - - + - + - + NA + - + - - - 
Engagement at the 
managerial level 
Team of people who work 
together coordinating IPV 
activities within the health 
system (official or not but 
functioning)2 
13 (76) + + + - - - + + - + + + + + + + + 
Exists a person or group 
officially recognized for 
managing the health 
system’s response to IPV3 
6 (35) - - + - - - - - - - + + - + - + + 
Health sector 
integrated in an 
intersectorial 
response 
Protocol for intersectorial 
response to IPV published 
and includes health sector4 
13 (76) + + + + + - + + + + + - + - - + + 
Exists an intersectorial body 
for dealing with IPV 
(committee, plan, etc.) in 
which health sector included 
15 (88) + + + + + + + + + + - - + + + + + 
1
 In certain autonomous regions, like C Valenciana and La Rioja, health system’s management is not based on “program contracts”. 
2
 A team existed in Canarias until 2010, but not longer afterwards. At team existed in Baleares until November 2011. 
3
 There was somebody designated in Cataluña RHS but no longer. 
4
 In Murcia the protocol was developed before December 2012, but was passed in 2013. In Madrid there are plans at the municipal level, but not at the regional level. 
5
 Total refers to the number of RHSs in which the indicator was present, against the total number of RHSs. The raw number and the percentage (in brackets) are provided. 
Implementing a supportive national structure 
Participants acknowledged that the 2004 Gender Based Violence Law constituted a 
cornerstone for building an enabling policy environment. The law detailed the health sector’s 
responsibilities and supported earlier regional initiatives, to guide the main lines of work on 
IPV in the national health system. It also pushed for the development of enabling structures 
within the national health system, such as the NCGBV and the working groups. These 
structures enhanced cohesion between the RHSs and made it possible to reach consensus 
regarding guidelines, indicators, and training objectives. They also served to build an inter-
regional network, where RHSs have been able to exchange experiences and good practices 
and support each other’s efforts. Worth highlighting is that while the NCGBV was comprised 
of policy makers, the working groups were constituted by a variety of professionals, both 
civil servants in the regional health systems and professionals involved in clinical work. The 
guiding role of the Observatory was highly valued by participants. 
Within this space you get working guidelines, funding, coordination is 
established, and it’s a cornerstone. It’s a meeting point, and the fact that we 
[the RHSs] have to submit an annual report puts everybody to work, it’s a 
strategy that develops cohesion. I think that the Observatory fulfils that 
function. E6 
Strong voluntarism aimed at increased institutionalization 
Participants expressed the importance of building teams of people interested in IPV to 
coordinate the activities in each of the RHSs. Those teams of civil servants with expertise on 
IPV had close links with clinical practice and had strong motivations to mobilize the work on 
IPV within the RHSs. In some regions, informal working teams-that included both civil 
servants at the managerial level and professionals working at health care facilities-were 
created in order to better accommodate the needs of first line health care practitioners. 
However, the civil servants in charge of IPV within the RHSs had to overcome three main 
barriers: 1) they had other responsibilities besides IPV, and many lacked official designation, 
making them vulnerable to political turnovers; and 2) the lack of commitment of certain 
political stakeholders. In general, these stakeholders had a medicalised approach to IPV and 
consequently might not necessarily consider investing in actions aimed at prioritizing IPV 
and improving the response of health services. This second barrier was described by one of 
the interviewees: 
When I started working in 2006, since there was money for IPV I went to see 
my boss and said: Hey, you should give me some money to train on gender 
based violence”, and he asked me: How many women died in this autonomous 
community due to gender based violence last year? I said, “None”, and he 
continued: “Every day I have 10 deaths due to cardiovascular diseases, so 
you can understand I am going to allocate very little money to gender based 
violence”. E3 
Achievements in IPV response were considered to be a result of the motivation and 
voluntarism of specific individuals, whether policy makers, civil servants or clinicians. 
Voluntarism was highly valued, but at the same time participants recognized that it could not 
stand alone without institutionalization of the actions and structures that have been built. 
The ups and downs of inter-sector coordination 
Participants acknowledged that the health sector alone could not respond effectively to IPV 
and valued the coordinating efforts developed in the RHSs. They valued the existence of 
structures for such coordination-like commissions, agreements and protocols-but also 
acknowledged the key role of interacting face-to-face with those responsible in other sectors. 
Collaboration with other sectors was considered a facilitator for the establishment of referral 
networks between health care facilities and other services, in order to offer a comprehensive 
response to women exposed to IPV. 
Coordinating between different sectors also brought challenges: 1) rivalry in terms of who 
should lead the process, 2) difficulties dealing with a weakened referral network due to cuts 
in social services, and 3) reaching agreement between different approaches. Regarding the 
latter, participants were especially worried about the conflict between a judicial approach to 
IPV-that focused on reporting-and a broader approach–favoured by health providers-that did 
not prioritize legal solutions. 
Currently there is a tendency towards judicialisation that focuses on “report, 
report”. The law forces us to report, and women also have to report, in order 
to have the right to certain social benefits; but the path is a bit too rigid […] 
The relationship with the judicial system is difficult, because it’s a very 
hierarchical system and very hermetic…, probably like medicine, but they are 
a State power, and that puts them at another level. E18 
Although some concrete experiences of coordination between the educational and the health 
sectors were mentioned, participants considered that the former has generally been absent in 
these regional intersectorial coordination bodies. 
Protocols and guidelines steering the healthcare response 
All of the 17 RHSs have published protocols/guidelines to guide health services’ response to 
IPV. Focus has been put on primary health care. The RHSs’ protocols fulfilled most of the 
WHO criteria that refers to health providers’ practices and emotional support. Regarding non-
negotiable issues, two criteria were not explicitly mentioned in the majority of protocols: 1) 
that providers should not contact a woman’s partner (mentioned in only 8 out of 17), and 2) 
that providers should not refer women to traditional couples counselling (9 out of 17). The 
importance of ensuring confidentiality was addressed in 15 of the protocols, but only 4 
explicitly mentioned the importance of keeping clinical records confidential. Only 3 of the 
RHSs incorporated routine inquiry for IPV into antenatal care. The need to explore the 
situation of children of victims of IPV, and the need to consider women in situations of 
vulnerability, appeared in 10 and 7 protocols respectively. See Table 2. 
Table 2 Indicators related to protocols and guidelines (based on the latest published) 
 TOTAL n 
(%)3 
Andalucía Aragon Asturias Baleares Canarias Cantabria C-La 
Mancha 
C-
Leon 
Cataluña C 
Valencia 
Extremadura Galicia La Rioja Madrid Murcia Navarra País 
Vasco 
Criteria Indicator 
Clinical guidelines in 
place and 
implementation 
monitored1 
Regional protocol and/or 
guidelines published 
17 (100) + + + + + + + + + + + + + + + + + 
Health providers’ 
practices. Protocol 
clearly includes 
regarding Primary 
health care: 
The need to document what the 
woman says and collect forensic 
evidence if needed 
16 (94) + + + + + + + + + + - + + + + + + 
The need to give information about 
crisis services and long-term 
services 
16 (94) + + + + + + + + + + - + + + + + + 
The need for safety planning 15 (88) + + + + + + + + + + + + + + + - - 
The need for organize referrals 
(within the health care facility or 
external) 
17 (100) + + + + + + + + + + - + + + + + + 
Emotional and 
psychosocial 
support. Protocol 
includes regarding 
Primary health care: 
The need to validate women’s 
experiences 
15 (88) + + + + + + + + + + - + + + + + - 
The need to have non-judgmental 
attitudes 
15 (88) + + + + + + + + + + - + + + + + - 
The need to listen, assess the risk, 
evaluate the woman’s expectations 
and provide options 
14 (82) + + + + + + - + + + - + + + + + - 
The need to believe what the 
woman is saying, empathize and 
not belittle her experiences 
15 (88) + + + + + + + + + + - + + + + + - 
Non-negotiable 
issues. Protocol 
includes regarding 
Primary health care 
that the health 
providers should: 
Avoid contacting the woman’s 
partner2 
8 (47) - - - - + + - - + + - - - + + + + 
Avoid referring to traditional 
couple counselling2 
9 (53) + + - - + - - + - - - + + + + + - 
Ensure absolute confidentiality2 15 (88) + + + + + + + + + + + + + + + - - 
Keep medical records somewhere 
confidential 
4 (24) - - - - - - - + - + - - - + + - - 
Ensure that woman’s decision 
prevail and she should be allowed 
to take action when she wants 
13 (76) + - + + + + - + + + - + + + + + - 
Screening and 
clinical inquiry. 
Protocol includes 
regarding Primary 
health care: 
Routine inquiry in antenatal care 3 (18) - - - - + + - + - - - - - - - - - 
How to do appropriate clinical 
inquiry if signs 
15 (88) + + + + + + + + + + - + + + + + - 
Link IPV with child 
protection 
The protocol states the need to 
explore with women how their 
children are treated 
10 (59) + + - + + + - + + - - + + + - - - 
Focus on women in 
situation of 
vulnerability 
Protocol mentions the need to 
consider women in situations of 
vulnerability 
7 (41) + - + + + - - + - - - - + + - - - 
1
 In some regions, like Castilla León there are more than one protocol, each addressing different aspects. 
2
 In Aragón, even if the protocol does not explicitly include these aspects, they are addressed in the training. In La Rioja, even if it is not explicitly written to avoid contacting the partner, issues regarding 
difficulties when women came accompanied are addressed. 
3
 Total refers to the number of RHSs in which the indicator was present, against the total number of RHSs. The raw number and the percentage (in brackets) are provided. 
Participatory development of guidelines 
Participants described the development of protocols as a participatory process, with a rich 
process of exchange between different levels. The national protocol for a health sector 
response to IPV, published in 2007, served as a base for the regions that had not published 
protocols up to that time, while the regional protocols that had been published before that 
date were also taken into account when developing the national protocol. Experiences from 
one autonomous region inspired the elaboration of protocols in other regions. 
In order to develop our regional protocol, we first looked into the other 
protocols that had been published and their contents, and we developed our 
protocol based on that. I mean, we did not start from scratch, but since there 
were regions that were doing things, and they were doing them well, we took 
advantage of their experience. E7 
At the regional level, participants expressed that the development of the guidelines was the 
result of team work, with the involvement of professionals from different sectors and levels 
of the RHSs. Civil servants at the managerial level participated, as did general practitioners, 
paediatricians, midwifes, social workers, gynaecologists, psychologists working in health 
care facilities, and actors from other sectors. 
Clinical work: not just following the steps of the protocol 
Participants considered that one of the main aims of the protocols was to guide and support 
clinicians’ actions in detecting and responding to cases of IPV. Protocols were perceived as 
facilitating clinicians’ work by detailing the actions they should carry out, and as one 
participant stressed: 
The protocol is extraordinary since it leaves the professionals with no doubts. 
They know what to do at every moment, by following the protocol they know 
what to do, how to proceed, what to do on every occasion. The protocol leaves 
no room for improvisation. E15 
However, as one participant pointed out “when a protocol is developed, that’s not the end of 
the work, in fact the real work starts at that very moment, when professionals have to be 
engaged” E19. Participants agreed that suspecting, detecting and questioning was not merely 
a matter of following the steps of a protocol but constitutes a learning process that 
professionals may or may not engage in. Dealing with IPV also demanded a different 
approach from providers, as the following quotation demonstrates: 
The health professional doesn’t have all the answers, as when faced with 
biomedical problems; for example, faced with pneumonia, the health 
professional will know far more than the patient, […] if the patient follows the 
treatment, she/he will get better. With IPV, it’s not like this, […] the health 
professional lacks the answer in terms of what to do tomorrow, or the day 
after tomorrow, when facing her husband, her son […]. What she/he can do is 
open doors, give clues, and help the woman to make up her mind. E 23 
Training of health professionals 
Nine RHSs had training plans published, and 14 have a team of health providers with 
expertise on IPV able to engage in training others. These are mostly clinicians who were not 
dedicated full-time to this task but who could be available if needed. Measures to facilitate 
training included substitutions (in 5 of 17) and the inclusion of IPV training targets into 
“program contracts” (7 out of 17). 
Eleven out of 17 RHSs have included issues of IPV into the training of doctor/nurse 
residents, but none of the autonomous regions have institutionalized training on GBV within 
undergraduate training. See Table 3. 
Table 3 Indicators related to training of health professionals 
 TOTAL 
n (%)4 
Andalucía Aragon Asturias Baleares Canarias Cantabria C-La 
Mancha 
C-
Leon 
Cataluña C 
Valenciana 
Extremadura Galicia La Rioja Madrid Murcia Navarra País 
Vasco 
Criteria Indicator 
Training plan (as 
per 2011) 
Official training plan 
published/ institutionalized 
or formalized 
9 (53) + - + + - + + + - + - - - + + -  
Trained 
professionals and 
training team (as 
per 2011) 
Exists a group of trainers 
within the autonomous 
region 
14 (82) + + + + + - - + + + - + + + + + + 
Trainers with 
multidisciplinary profiles 
(three or more)- during 
2011 
16 (100) + + + + + + + + NA + + + + + + + + 
Measures to 
facilitate 
participation on 
training (as per 
2011) 
Substitutions1 5 (31) - - - + - + - - + + NA - - - - + - 
Program contracts2 7 (47) + - + + - - - + NA + NA - - + - - + 
Supervision and 
reinforcement (as 
per 2011) 
Training plan includes 
issues of supervision and 
support3 
2 (14) - - + - - - - - NA - - NA - + - - NA 
Training included 
in undergraduate 
curricula (as per 
2011) 
Some training on GBV 
included in the curricula of 
health studies 
(undergraduate or 
specialization) 
11 (69) - + + + + + NA + - + - + + - + + NA 
GBV management officially 
included in the curricula of 
health studies 
0 (0) - - - - - NA - - - - - - - - - - NA 
1
 In Baleares existed until 2011, but not in 2012 and beyond. In Asturias existed until 2010. 
2
 In Madrid is explicitly included from 2012, before it was included as part of the “training on strategic lines”, being GBV included among these lines. 
3
 In Aragón health providers receive actualized information on IPV; i.e. new policies. 
4
 Total refers to the number of RHSs in which the indicator was present, against the total number of RHSs. The raw number and the percentage (in brackets) are provided. 
Building a network of sensitized professionals 
Participants considered that training activities organized in the RHSs served to build a 
network of health professionals who are sensitized and knowledgeable about IPV and who 
can support one another. Participation in courses on IPV have not been compulsory for health 
professionals, but a number of strategies to encourage and facilitate participation have been 
implemented, such as including training targets into “program contracts”, ensuring 
substitutions of professionals who attended training, and offering accreditation/certificates 
that could be used for career advancement. In some regions, training sessions included the 
participation of professionals from other sectors (police, judicial system, social services) in 
order to enhance collaboration and facilitate referrals from health professionals to other 
services. 
Participants considered that training health professionals during their undergraduate studies is 
very important, but acknowledged that they have little power to influence universities’ 
curricula. 
When I asked [the new medical and nursing residents] whether they had 
received training on IPV during their university education, none recalled 
having had such training […]; I mean, they have studied six years of medicine 
and nothing, no idea. E6. 
Progress made and current uncertain sustainability 
Participants were convinced of the progress achieved. They recalled that they were pioneers 
when they started, facing opposition from providers at the clinical and managerial levels. 
They recalled that they were uncertain on how to proceed and lacked guidelines or expertise, 
but that they started because they felt there was a need to act on this problem. 
There has been a specific training strategy [on IPV] directed towards health 
providers. We have been training for more than 10 years now, and that has 
been crucial […]. I notice a dramatic change; I mean, in the beginning when I 
talked about violence to health providers, they were resistant and replied that 
there was nothing that they could do: they were annoyed…, even those who 
voluntarily participated in IPV training workshops! E13 
Evaluations have been scarce and were mainly limited to before and after assessment of 
knowledge or participants’ satisfaction with courses. Participants were uncertain regarding 
the extent to which training had made an impact on clinical practice. They also expressed that 
the lack of sustained strategies for supervising and supporting providers after they were 
trained might limit the impact of training sessions on changes in clinical practices. 
They also considered that further training of more providers was still needed. In this sense, 
they were worried about the current economic situation. Funding for training activities–in 
general and specifically for IPV-had decreased, and strategies to facilitate participation in 
training had been dismantled. Additionally, providers’ salaries had decreased in some RHSs, 
and their workload had increased, resulting in a scenario in which professionals were not 
motivated to participate in training activities. 
Accountability and monitoring 
As per 2011 indicators (the most recent available), four RHSs had collected and reported all 
of the 11 common indicators on IPV agreed upon in the NCGBV. Detection rates-defined as 
the number of new cases of violence among women age 14 and older detected by the health 
sector per 100, 000 women of that age-varied widely between the RHSs. It ranged from 6.58 
in Extremadura to 172.05 in Andalucía. The 11 common indicators did not provide 
information regarding the quality of the IPV services provided, but such indicators were 
collected in 2 RHSs, and another one had implemented reporting systems that will enable 
them to collect such information in 2013. 
None of the RHSs had implemented measures for supporting the debriefing of professionals 
dealing with cases of IPV. Similarly, none had implemented systematic mechanisms to 
collect information on women’s experiences with the services, although studies had been 
conducted in some RHSs to assess women’s experiences with IPV and their perceptions of 
the services provided. See Table 4. 
Table 4 Indicators related to accountability and monitoring 
 TOTAL 
n (%)3 
Andalucía Aragon Asturias Baleares Canarias Cantabria C-La 
Mancha 
C-Leon Cataluña C 
Valenciana 
Extremadura Galicia La Rioja Madrid Murcia Navarra País 
Vasco 
Criteria Indicator 
Monitoring system that 
provide data on number 
of cases 
All the 11 Common 
national indicators 
collected and reported 
in 2011 (in brackets 
number collected) 
4 (25) - - - - - + NA + - - + - + - - - - 
Increase on detection 
rates within health 
system from 2009 to 
2011 (National 
Indicator 1) 
6 (43) - + + - - + - + NA + NA NA + - - - - 
Indicators regarding 
quality of services 
provided collected (13 
to 15 or others similar) 
in 20111 
2 (12) - - - - - - - - - + - - + - - - - 
Debriefing support for 
health professionals 
Procedures for 
debriefing support 
established 
0 (0) - - - - - - - - - - - - - - - - - 
System to learn from 
women’s experiences of 
the service 
Procedures to collect 
information from 
women’s experiences 
exist2 
0 (0) - - - - -  - - - - - - - - - - - 
1
 In Castilla-Leon, the reporting system within the electronic clinical records allows the collection of such indicators, but since this has been recently implemented, those data were not available for use. In 
Aragón Indicators 13 and 15 are collected but not further used at the moment. 
2
 In Madrid the Demographic survey is conducted annually since 2004 and collects data on service utilization, but not on experiences of women victims of IPV with existing health services. 
3
 Total refers to the number of RHSs in which the indicator was present, against the total number of RHSs. The raw number and the percentage (in brackets) are provided. 
Weaknesses of existing systems: design, application and data utilization 
Participants mentioned several limitations of the existing reporting systems. First, the existing 
codes in most primary health care diagnostic tools were not specific for IPV. Using them may 
mean that cases of IPV might be split among diverse codifications or that certain codes might 
include not only IPV but also other forms of violence, hindering the collection of specific 
information. 
When we started collecting the number of IPV diagnoses, we got very high 
numbers in comparison with other autonomous regions […]. We changed the 
diagnosis codes we were using, because we realized that what we were 
collecting was any type of violence, not just violence by a current or former 
partner. E10 
Second, participants expressed that primary health care and specialized services often had 
different electronic systems that made it impossible to follow a case through different health 
care levels. This made follow-ups difficult and resulted in possibilities for duplication. 
Third, applying the registration systems was more easily said than done. Participants 
considered that IPV registration was still in the early stages, with consequent errors and 
underreporting. Moreover, since cases of IPV were not detected frequently, professionals did 
not use IPV registration systems often, and when they had to do so, they were not necessarily 
familiar with them. 
Fourth, data gathered was considered to be under-utilized. Besides reporting to the NCGBV, 
the information that emerged from collected indicators was not used for monitoring the work 
of the health services. Collected information was not returned to the health facilities that 
produced it, and participants considered that this could further discourage professionals’ 
proper registration of cases. 
Finally, participants mentioned that the registration of IPV might generate conflicts/dilemmas 
among health providers. Despite the fact that access to electronic clinical records was limited 
to certain professionals, doubts about confidentiality and women’s safety were raised, for 
example, recorded IPV-related information could be seen by the woman’s partner on the 
computer screen during consultation. Writing down codes related to IPV-that might be seen 
by other health care professionals consulted by the woman-could further stereotype women, 
as one participant highlighted, “Putting codes [regarding IPV] also means…, thinking twice, 
it means labelling, you keep on labelling women” E12. 
Prevention and promotion–supposedly a priority but not prioritized in 
practice 
It was not possible to collect quantitative information on this indicator, since none of the 
RHSs had institutionalized actions regarding primary prevention of IPV or the promotion of 
women’s empowerment within the health systems. Qualitative information portrayed primary 
prevention actions as important. 
It is crucial to begin actions with young people, because if you start working 
at that moment, you can prevent violence before it happens: I think we need to 
focus on prevention, primary prevention, before IPV starts… Then I think we 
need to work with young people on prevention. E13 
Qualitative interviews allowed the collection of information on specific preventive-
promotional experiences in some of the RHSs, for example, coordinated work among 
women’s and community organizations, therapeutic work with groups of women addressing 
their malaise, and initiatives to promote more gender-equal and non-violent relationships 
among young people. 
Participants stated that in some RHSs, actions aimed at prevention and/or promotion were 
starting to be incorporated into health plans and guidelines, but this was perceived as still 
incipient, not the focus of this first stage, and not generalized. They considered that engaging 
in prevention and promotion actions was very much dependent on the motivation and 
willingness of particular professionals and/ or health care teams. The high demands that 
health care professionals already had with curative services were also mentioned as a further 
hindrance to the implementation of such activities. 
[Regarding preventive activities] No, no, we haven’t been able to engage in… 
It hasn’t been, it hasn’t surfaced as a priority, even if we knew it was a 
priority, but we had to focus on other issues […] we have tried to develop a 
guide for professionals on prevention; we are working on that but it is a very 
slow process, very slow […] We have to try preventive actions and not merely 
be dependent on the willingness of certain individuals, because we can’t ask 
for more [from providers], since they are already too busy. E19 
Discussion 
This study maps and explores the integration of IPV within the Spanish decentralized health 
system in relation to the WHO recommendations on health sector responses to violence 
against women. It highlights the noteworthy progress achieved in a short period of time, 
especially in terms of legislation, high-level policy-making, and the development of a 
national coordination structure for learning, sharing and building consensus. Strategies to 
facilitate implementation of overarching policies at the level of health services have been put 
in place, especially in terms of the development of guidelines and efforts towards sensitizing 
and training health providers. National structures made strong efforts to incorporate regional 
initiatives, and reach consensus and strengthen cohesion, but the large differences between 
regions show that there is still work ahead. In light of the WHO recommendations, some 
challenges remain, such as the strengthening of monitoring systems, intersectorial 
coordination, and primary prevention actions. 
Results show that RHSs align with the national level in terms of passing IPV legislation that 
includes the health sector. According to street-level bureaucrat theory, health policy 
implementation is highly dependent on individual civil servants; they play an important role 
and should be taken into account [41,42]. Getting these civil servants “on board” is 
paramount when potentially controversial programs are to be integrated. This study shows 
that in Spain, interventions geared towards IPV integration have considered the key role of 
these actors. The interventions have been participatory and in-line with a bottom-up approach 
to policy implementation [41,43]. Great efforts have been put into building a network of 
sensitized people with expertise on IPV who are convinced of the need to integrate it into the 
health system and motivated to take on this task. 
Protocol or clinical guidelines were present in all regions. The aim of protocols was to guide 
the health providers’ work in terms of IPV, and they can also be seen as a marker of political 
commitment. However, participants in this study vacillated between considering protocols as 
the perfect tool to ensure an adequate response and considering that responding to IPV 
demanded much more creativity and competence from providers. This is in-line with other 
studies that indicate that dealing with and responding to IPV is an emotionally charged issue 
that involves a great deal of uncertainty [15,44]. Managing such uncertainty and adapting to 
the different needs of a diverse group of survivors of IPV can be supported by good 
guidelines, but it also requires investment in training and sensitizing providers. 
Training has been a cornerstone for enabling providers to have sufficient skills to detect and 
manage IPV. However, available indicators do not facilitate evaluating the impact of those 
programs, because percentages of trained providers per region were not available, and few 
RHSs have published training manuals whose contents could be assessed. Training actions 
demonstrate a great deal of creativity, combining different approaches, duration and sites. 
One weakness noticed was of the limited supervision and support after training, a key 
component of successful incorporation of training into clinical practice [9]. Another is related 
to the weak integration of IPV training components within university training, an issue that 
has also been reported elsewhere [15,19]. 
This study also shows that comprehensive IPV legislation does not immediately translate into 
changes in the structure of the health systems; i.e. the inclusion of IPV as a component of 
regional health plans was not generalized, and health system’s strategies aimed at prioritizing 
certain health programs–such as “program contracts”-seldom included IPV within their 
targets. That IPV policy has difficulty in terms of follow-through has been pointed out 
elsewhere [45]. It might be due to the hegemony of the biomedical approach in the majority 
of health systems, which might not facilitate a comprehensive inclusion of complex issues 
such as IPV [14,44]. 
This study also demonstrates that institutionalized change [26] such as shifts in policy, 
protocols and organizational practices and structures still remain to be developed. Individual 
willingness and voluntarism remains a strong driver for actions, and it should be 
acknowledged that this motivation has generated changes all over the country. However, 
sustaining programs that rely on individual motivation becomes difficult if organizational 
structures do not change [13,27,46]. In terms of institutionalization of policies and programs, 
budget assignment is key. For this study it was not possible to get information regarding the 
budget allocated to IPV activities within the health system. This could be a sign of the fact 
that such programs face uncertain and poorly established funding channels within the health 
systems. The study also shows that participants considered that austerity measures have a 
negative impact on IPV programs, both in general and within the health system. 
There were certain issues that the WHO recommendations considered as non-negotiable and 
that were less frequently included in the protocol. One such issue was the prohibition of 
contact with the partner. There is international consensus that not contacting the partner and 
always ensuring the privacy and confidentiality of the woman is necessary in order to protect 
her from further harm. The role of the health providers is to ensure that women exposed to 
IPV receive the best care with respect to her privacy and confidentiality [1,6]. However, due 
to the way Spanish primary health care practices are organized, avoiding all contact with the 
partner of a woman exposed to IPV is difficult. General practitioners in Spain are assigned 
entire families (husband, wife and children), and consequently when they detect a case of IPV 
they usually have been in contact with the woman-and her partner-for a long time. As a 
result, “not contacting the partner” is virtually impossible. Even if general practitioners can 
avoid addressing the issue of IPV with the partner, they must always deal with the fact that 
the perpetrator of the abuse is also a patient. This problem can be solved either by assigning 
the partner to another doctor-which could raise suspicion-or by continuing to provide care for 
the partner without mentioning the issue of IPV. It is an issue for which clear guidelines are 
absent. Hegarty et al. comment on this issue [47], and future WHO recommendations should 
take into consideration how to best advise providers dealing with such situations. 
Another aspect that was not explicitly addressed in the majority of the protocols is that of 
ensuring that clinical records are kept in a confidential place. This could be due to the fact 
that clinical records in Spain are electronic and paper copies are not kept. However, even 
with electronic records, problems with privacy and confidentiality can occur. The need to 
monitor treatment of children is an important component of the health sector response to IPV, 
but few regional protocols provide explicit advice on this. It is important to note that the new 
national protocol more explicitly addresses these two issues, and it is likely that a revision of 
the regional protocols will take place accordingly [48]. 
Routine inquiry during pregnancy has proven to be an effective strategy [49-51], and it is 
included in the WHO recommendations. However, routine inquiry during pregnancy was 
institutionalized and/or included in the protocols in only 3 RHSs. The new national protocol, 
unlike the previous one, incorporates clinical inquiry of all women-pregnant or not-and 
explicitly addresses the special vulnerability of women to IPV during pregnancy [48]. 
Probably, this will lead to an increase in the application of clinical inquiry during pregnancy. 
The NCGBV, the working groups and the Observatory have developed a set of common 
indicators to assess the situation of IPV and monitor trends. However, accountability and 
monitoring systems still face many challenges. Some limitations refer to the methods used to 
collect and analyze data; different diagnostic codes are used to label IPV cases (maltreatment, 
interpersonal violence, spousal abuse), and a diagnostic code that is both sensitive and 
specific has still not been incorporated into the electronic clinical records. This has also been 
reported in one previous study in Asturias (Spain) and elsewhere [16,52]. Data on existing 
indicators varied enormously from region to region, and was very low when compared to 
prevalence data from other studies [33,53] pointing out not only differences in regional 
functioning but also inaccuracies in reporting systems. Information collected was neither 
provided to the health care team producing it, nor used for monitoring purposes. An 
additional weakness in Spanish RHSs was the inexistence of mechanisms to collect 
information on women’s perceptions of the services. Several studies show that women’s 
perceptions can be very different from providers’ perceptions, and since many studies show 
that women’s experiences with services are not positive, there is need to further consider their 
perspective in order to improve the services offered [14,22,54-56]. 
It is essential to note that information regarding prevention/promotion activities was scarce. 
On the one hand, since the majority of factors associated with IPV belong to the social 
sphere, it is difficult to determine the health sector role and what lies beyond its 
responsibilities [57]. On the other hand, both public health and primary health care focus on 
prevention and promotion [58]. In recent decades, primary health care in Spain-and 
elsewhere-has become less prevention-oriented and more medicalised. Increased demand has 
reduced consultation hours, further hindering the work of professionals at this level [59]. This 
scenario reduces the likelihood that the health system will institutionalize preventive actions 
regarding IPV, and may leave such actions dependent on the voluntarism of select 
professionals and services. It is however, hopeful that the new protocol includes a section on 
the Integral Approach to Health, as the base for adequate integration of an IPV response [48]. 
The literature shows that few national IPV laws explicitly address the responsibilities of the 
health sector [28,29]. This paper constitutes a first attempt to establish concrete criteria to 
define and assess the responsiveness of health systems to IPV, beyond the statements 
contained in the legislation. By better defining such criteria it will be possible to monitor to 
what extent health services are responding to the needs of women exposed to IPV, and to 
establish mechanisms for improvement. We consider that these indicators could serve as a 
starting point to assess how health systems outside Spain are responding to IPV. 
This paper highlights the issues in Spain that should be improved in order to better respond to 
the needs of women exposed to IPV. These issues include stronger institutionalization of the 
health care response to IPV such that the response offered to women is less dependent on 
professionals’ personal motivation, a better monitoring system that takes into account 
women’s perceptions, and a stronger focus on primary prevention. The differences between 
regional health systems also underscores the need to harmonize the strategies carried out, in 
order to ensure that the quality of health care received by a woman exposed to IPV is not 
dependent on the region where she lives. 
Limitations and strengths 
This paper constitutes a first attempt to map and explore the integration of IPV within a 
health system. As with any first attempt, there are a number of limitations to be 
acknowledged, amongst them: 1) the selection of indicators is based on WHO 
recommendations and also on data available in Spain, and it is arguable whether they 
constitute the gold-standard for analyzing health system responsiveness to IPV, 2) 
information was collected at just one point in time, which does not enable a chronological 
picture of advances and regression, 3) it was not possible to collect data on some issues such 
as funding or actual practices that are very relevant for assessing a health system’s 
responsiveness to IPV, 4) in general, participants were highly motivated people, and as such 
they may have portrayed an overly positive picture of the Spanish health system’s response to 
IPV, and 5) the study portrays the Spanish health system response as the combination of the 
regional responses, without putting much focus on the national level aspects and the 
relationship between regions. Furthermore, it would have been interesting to explore why 
regional differences in health system’s response to IPV exist, but we did not collect that 
information during the interviews since the aim of the study was not to explore in depth 
regional differences, but to give an overview of the situation in Spain. 
There are also a number of strengths to be highlighted: 1) the research design allowed for 
triangulation of information from the public document review and the qualitative interviews, 
which enriched the findings and allowed the description of both the broad (mapping) and 
deeper (exploring) perspectives, 2) the emergent design allowed data collection and analysis 
steps to be responsive to emergent findings, 3) the study collects disaggregated information at 
the regional level, allowing comparisons, and 4) the case selected (Spain) offered a rich 
scenario due to the number and diversity of strategies that have been implemented as part of 
the health care response to IPV. 
Conclusion 
The study puts into evidence different levels of achievements between RHSs and also 
between the five areas assessed. Progress has been made at the level of policies, while it is 
less outstanding regarding health service delivery, and very limited in terms of preventive 
actions. There are still challenges remaining for a comprehensive integration of IPV response 
within the Spanish health system such as, 1) establishment of good coordination with other 
sectors despite their different approaches to IPV, 2) incorporation of new issues, such as 
routine inquiry in antenatal care, into the protocols, 3) strengthening mechanisms to improve 
accountability systems in order to enhance their specificity as well as the use of data for 
reorienting programs, 4) exploring ways to strengthen work on prevention and promotion 
activities, and 5) sustaining the progress made in the face of increased uncertainty and 
shrinking resources due to the recently implemented austerity measures. 
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